Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NONSTEROIDAL ANTIINFLAMMATORY DRUGS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 3599 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Friis, S; Nielsen, GL; Mellemkjaer, L; McLaughlin, JK; Thulstrup, AM; Blot, WJ; Lipworth, L; Vilstrup, H; Olsen, JH
      Cancer risk in persons receiving prescriptions for paracetamol: A Danish cohort study

      INTERNATIONAL JOURNAL OF CANCER
    2. Scott, CS; Retsch-Bogart, GZ; Henry, MM
      Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen

      PEDIATRIC PULMONOLOGY
    3. Fitzpatrick, FA
      Inflammation, carcinogenesis and cancer

      INTERNATIONAL IMMUNOPHARMACOLOGY
    4. Wayne, JD; Wolff, RA; Pisters, PWT; Evans, DB
      Multimodality management of localized pancreatic cancer

      CANCER JOURNAL
    5. Williams, CS; Sheng, HM; Brockman, JA; Armandla, R; Shao, JY; Washington, MK; Elkahloun, AG; Dubois, RN
      A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established humancolon cancer xenografts

      NEOPLASIA
    6. Gallo, O; Franchi, A; Magnelli, L; Sardi, I; Vannacci, A; Boddi, V; Chiarugi, V; Masini, E
      Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

      NEOPLASIA
    7. Hochberg, MC; Dougados, M
      Pharmacological therapy of osteoarthritis

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    8. Wallace, JL
      Pathogenesis of NSAID-induced gastroduodenal mucosal injury

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    9. Aalykke, C; Lauritsen, K
      Epidemiology of NSAID-related gastroduodenal mucosal injury

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    10. Smale, S; Tibble, J; Sigthorsson, G; Bjarnason, I
      Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    11. Bidaut-Russell, M; Gabriel, SE
      Adverse gastrointestinal effects of NSAIDs: consequences and costs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    12. McCarthy, DM
      Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    13. Bazzoli, F; De Luca, L; Graham, DY
      Helicobacter pylori infection and the use of NSAIDs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    14. Stack, E; Dubois, RN
      Regulation of cyclo-oxygenase-2

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    15. Hawkey, CJ
      COX-1 and COX-2 inhibitors

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    16. Giercksky, KE
      COX-2 inhibition and prevention of cancer

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    17. Howden, CW; Leontiadis, GI
      Current indications for acid suppressants in Helicobacter pylori-negative ulcer disease

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    18. Chan, FKL; Sung, JJY
      Role of acid suppressants in prophylaxis of NSAID damage

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    19. Lingenfelser, T; Ell, C
      Lower intestinal bleeding

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    20. Forshaw, MJ; Zayyan, K; Power, DM
      NSAID-induced small bowel perforation

      ANZ journal of surgery
    21. Belluzzi, A
      N-3 and n-6 fatty acids for the treatment of autoimmune diseases

      EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
    22. Arlt, GD; Leyh, M
      Incidence and pathophysiology of peptic ulcer bleeding

      LANGENBECKS ARCHIVES OF SURGERY
    23. Martin, MJ; Jimenez, MD; Motilva, V
      New issues about nitric oxide and its effects on the gastrointestinal tract

      CURRENT PHARMACEUTICAL DESIGN
    24. Rodriguez-Tellez, M; Arguelles, F; Herrerias, JM; Ledro, D; Esteban, J; Herrerias, JM
      Antiinflamatory agents less dangerous for gastrointestinal tract

      CURRENT PHARMACEUTICAL DESIGN
    25. Takeuchi, K; Tanaka, A; Suzuki, K; Mizoguchi, H
      Gastrointestinal sparing anti-inflammatory drugs - Effects on ulcerogenic and healing responses

      CURRENT PHARMACEUTICAL DESIGN
    26. Jackson, CG
      Therapeutic potential of COX-2 inhibitors in arthritis

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    27. Geiger, J
      Inhibitors of platelet signal transduction as anti-aggregatory drugs

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    28. Sramek, JJ; Veroff, AE; Cutler, NR
      The status of ongoing trials for mild cognitive impairment

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    29. Howe, LR; Subbaramaiah, K; Brown, AMC; Dannenberg, AJ
      Cyclooxygenase-5: a target for the prevention and treatment of breast cancer

      ENDOCRINE-RELATED CANCER
    30. Oviedo, JA; Wolfe, MM
      Clinical potential of cyclo-oxygenase-2 inhibitors

      BIODRUGS
    31. Hoozemans, JJM; Rozemuller, AJM; Veerhuis, R; Eikelenboom, P
      Immunological aspects of Alzheimer's disease - Therapeutic implications

      BIODRUGS
    32. Colville-Nash, PR; Gilroy, DW
      Potential adverse effects of cyclooxygenase-2 inhibition: Evidence from animal models of inflammation

      BIODRUGS
    33. Mullins, CD; Thomas, SK; Roffman, DS
      Pharmaceutical restrictions - Possible effect on patient/physician buy-in of disease management programs

      DISEASE MANAGEMENT & HEALTH OUTCOMES
    34. Noveck, RJ; Laurent, A; Kuss, M; Talwalker, S; Hubbard, RC
      Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals - Two randomised, controlled trials

      CLINICAL DRUG INVESTIGATION
    35. Kivitz, AJ; Makarowski, WS; Fiechtner, JJ; Recker, DP
      A flexible daily dosage regimen of oxaprozin potassium in patients with acute knee pain associated with osteoarthritis - 24-hour analgesic durabilityand safety

      CLINICAL DRUG INVESTIGATION
    36. Belisari, A; Mantovani, LG
      Cost-benefit analysis of amtolmetin-guacil

      CLINICAL DRUG INVESTIGATION
    37. Peris, F; Martinez, E; Badia, X; Brosa, M
      Iatrogenic cost factors incorporating mild and moderate adverse events in the economic comparison of aceclofenac and other NSAIDs

      PHARMACOECONOMICS
    38. Herings, RMC; Klungel, OH
      An epidemiological approach to assess the economic burden of NSAID-inducedgas gastrointestinal events in The Netherlands

      PHARMACOECONOMICS
    39. Rahme, E; Joseph, L; Kong, SX; Watson, DJ; Pellissier, JM; LeLorier, J
      Gastrointestinal-related healthcare resource usage associated with a fixedcombination of diclofenac and misoprostol versus other NSAIDs

      PHARMACOECONOMICS
    40. Marshall, JK; Pellissier, JM; Attard, CL; Kong, SX; Marentette, MA
      Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis - Ontario ministry of health perspective

      PHARMACOECONOMICS
    41. Chevat, C; Pena, BM; Al, MJ; Rutten, FFH
      Healthcare resource utilisation and costs of treating NSAID-associated gastrointestinal toxicity - A multinational perspective

      PHARMACOECONOMICS
    42. Burke, TA; Zabinski, RA; Pettitt, D; Maniadakis, N; Maurath, CJ; Goldstein, JL
      A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis

      PHARMACOECONOMICS
    43. Zabinski, RA; Burke, TA; Johnson, J; Lavoie, F; Fitzsimon, C; Tretiak, R; Chancellor, JVM
      An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada

      PHARMACOECONOMICS
    44. Chancellor, JVM; Hunsche, E; de Cruz, E; Sarasin, FP
      Economic evaluation of celecoxib, a new cyclo-oxygenase 2 specific inhibitor, in Switzerland

      PHARMACOECONOMICS
    45. Pilotto, A
      Helicobacter pylori-associated peptic ulcer disease in older patients - Current management strategies

      DRUGS & AGING
    46. Weiner, DK; Hanlon, JT
      Pain in nursing home residents - Management strategies

      DRUGS & AGING
    47. Vargas, E; Cabrera, L; Moron, A; Garcia, M; Soto, J; Guadarrama, I
      Assessment of hospital costs related to the diagnosis and treatment of upper gastrointestinal haemorrhages in patients consuming non steroid anti-inflammatory drugs

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    48. Burillo, JMT; Melero, MJL; Marcet, AZ
      Epidemiologic aspects on nonvariceal upper gastrointestinal bleeding in a mediterranean region: incidence and sociogeographic and temporal fluctuations

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    49. Ripamonti, C; Fulfaro, F
      Pathogenesis and pharmacological treatment of bone pain in skeletal metastases

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    50. Fernandez-Lopez, F; Conde-Freire, R; Cadarso-Suarez, C; Garcia-Iglesias, J; Puente-Dominguez, JL; Potel-Lesquereux, J
      Sulindac in familial adenomatous polyposis: Evaluation by nuclear morphometry

      EUROPEAN JOURNAL OF SURGERY
    51. McCarthy, DM
      Helicobacter pylori and NSAIDs - What interaction

      EUROPEAN JOURNAL OF SURGERY
    52. Halpern, SH; Walsh, VL
      Multimodal therapy for post-cesarean delivery pain

      REGIONAL ANESTHESIA AND PAIN MEDICINE
    53. Siddik, SM; Aouad, MT; Jalbout, MI; Rizk, LB; Kamar, GH; Baraka, AS
      Diclofenac and/or propacetamol for postoperative pain management after cesarean delivery in patients receiving patient controlled analgesia morphine

      REGIONAL ANESTHESIA AND PAIN MEDICINE
    54. Coomber, BL; Nyarko, KA; Noyes, TM; Gentry, PA
      Neutrophil-platelet interactions and their relevance to bovine respiratorydisease

      VETERINARY JOURNAL
    55. Franchi, AM; Di Girolamo, G; Farina, M; de los Santos, AR; Marti, ML; Gimeno, MAF
      In vivo and in vitro effects of lysine clonixinate on nitric oxide synthase in LPS-treated and untreated rat lung preparations

      NITRIC OXIDE-BIOLOGY AND CHEMISTRY

    56. Upper gastrointestinal complications: The causes, consequences, and clinical outcomes

      AMERICAN JOURNAL OF MANAGED CARE
    57. Vakil, NB; Go, MF
      Debating the role of Helicobacter pylori infection

      AMERICAN JOURNAL OF MANAGED CARE
    58. Wu, SN; Jan, CR; Chiang, HT
      Fenamates stimulate BKCa channel activity in the human osteoblast-like MG-63 cells

      JOURNAL OF INVESTIGATIVE MEDICINE
    59. Borges, MS; Capriles-Hulett, A; Caballero-Fonseca, F; Perez, CR
      Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    60. Garcia-Cabanes, C; Palmero, M; Bellot, JL; Castillo, M; Orts, A
      Inhibition of COX in ocular tissues: An in vitro model to identify selective COX-2 inhibitors

      JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
    61. Naumann, BD; Silverman, KC; Dixit, R; Faria, EC; Sargent, EV
      Case studies of categorical data-derived adjustment factors

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    62. Vaszar, LT; Stevenson, DD
      Aspirin-induced asthma

      CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
    63. Ince, A
      The use of COX-2-specific inhibitors: Is it all hype or is it evidence based?

      JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    64. Lisse, J; Espinoza, L; Zhao, SZ; Dedhiya, SD; Osterhaus, JT
      Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib

      JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
    65. May, N; Epstein, J; Osborne, B
      Selective COX-2 inhibitors: A review of their therapeutic potential and safety in dentistry

      ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    66. Dormond, O; Foletti, A; Paroz, C; Ruegg, C
      NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis

      NATURE MEDICINE
    67. Singh, BB; Berman, BM; Hadhazy, V; Bareta, J; Lao, LX; Zarow, FM; Hochberg, M
      Clinical decisions in the use of acupuncture as an adjunctive therapy for osteoarthritis of the knee

      ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE
    68. Saukkonen, K; Nieminen, O; van Rees, B; Vilkki, S; Harkonen, M; Juhola, M; Mecklin, JP; Sipponen, P; Ristimaki, A
      Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma

      CLINICAL CANCER RESEARCH
    69. Srivastava, S; Verma, M; Henson, DE
      Biomarkers for early detection of colon cancer

      CLINICAL CANCER RESEARCH
    70. Li, M; Wu, XY; Xu, XC
      Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitorNS398 through a cytochrome c-dependent pathway

      CLINICAL CANCER RESEARCH
    71. Bing, RJ; Miyataka, M; Rich, KA; Hanson, N; Wang, XD; Slosser, HD; Shi, SR
      Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer

      CLINICAL CANCER RESEARCH
    72. Blumenthal, RD; Waskewich, C; Goldenberg, DM; Lew, W; Flefleh, C; Burton, J
      Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts

      CLINICAL CANCER RESEARCH
    73. Bradley, JD
      Celecoxib and rofecoxib: A distinction with a difference?

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    74. Francois, D
      Spin doctors

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    75. McKenna, F; Weaver, A; Fiechtner, JJ; Bello, AE; Fort, JG
      COX-2 specific inhibitors in the management of osteoarthritis of the knee:A placebo-controlled, randomized, double-blind study

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    76. Miura, T; Muraoka, S; Fujimoto, Y
      Phenylbutazone radicals inactivate creatine kinase

      FREE RADICAL RESEARCH
    77. Kojima, M; Morisaki, T; Uchiyama, A; Doi, F; Mibu, R; Katano, M; Tanaka, M
      Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas

      ANNALS OF SURGICAL ONCOLOGY
    78. Burkhardt, D; Hwa, SY; Ghosh, P
      A novel microassay for the quantitation of the sulfated glycosaminoglycan content of histological sections: its application to determine the effects of Diacerhein on cartilage in an ovine model of osteoarthritis

      OSTEOARTHRITIS AND CARTILAGE
    79. Harris, CJ; Brater, DC
      Renal effects of cyclooxygenase-2 selective inhibitors

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    80. Cleland, JGF; John, J; Houghton, T
      Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    81. Breyer, MD; Harris, RC
      Cyclooxygenase 2 and the kidney

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    82. Asea, PA; Patterson, JR; Korsrud, GO; Dowling, PM; Boison, JO
      Determination of flunixin residues in bovine muscle tissue by liquid chromatography with UV detection

      JOURNAL OF AOAC INTERNATIONAL
    83. Ashcroft, DM; Chapman, SR; Clark, WK; Millson, DS
      Upper gastroduodenal ulceration in arthritis patients treated with celecoxib

      ANNALS OF PHARMACOTHERAPY
    84. Erstad, BL
      Proton-pump inhibitors for acute peptic ulcer bleeding

      ANNALS OF PHARMACOTHERAPY
    85. Bates, DE; Lemaire, JB
      Possible celecoxib-induced gastroduodenal ulceration

      ANNALS OF PHARMACOTHERAPY
    86. Kanji, S; Dumo, P
      The effect of Helicobacter pylori eradication on NSAID-induced gastrointestinal toxicity

      ANNALS OF PHARMACOTHERAPY
    87. Bamberger, ME; Landreth, GE
      Microglial interaction with beta-amyloid: Implications for the pathogenesis of Alzheimer's disease

      MICROSCOPY RESEARCH AND TECHNIQUE
    88. Pohle, T; Herbst, H; Konturek, JW; Domschke, W
      Functional and structural studies on gastric mucosa and ulcer healing

      MICROSCOPY RESEARCH AND TECHNIQUE
    89. Calatayud, S; Barrachina, D; Esplugues, JV
      Nitric oxide: Relation to integrity, injury, and healing of the gastric mucosa

      MICROSCOPY RESEARCH AND TECHNIQUE
    90. Pohle, T; Becker, JC; Markmann, A; Lugering, N; Pauels, HG; Konturek, JW; Domschke, W
      Aspirin effects on gastric epithelial cell proliferation and cytokine expression

      MICROSCOPY RESEARCH AND TECHNIQUE
    91. Moysich, KB; Mettlin, C; Piver, MS; Natarajan, N; Menezes, RJ; Swede, H
      Regular use of analgesic drugs and ovarian cancer risk

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    92. Krishnan, K; Ruffin, MT; Normolle, D; Shureiqi, I; Burney, K; Bailey, J; Peters-Golden, M; Rock, CL; Boland, CR; Brenner, DE
      Colonic mucosal prostaglandin E-2 and cyclooxygenase expression before andafter low aspirin doses in subjects at high risk or at normal risk for colorectal cancer

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    93. Clinard, F; Sgro, C; Bardou, M; Dumas, M; Hillon, P; Bonithon-Kopp, C
      Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-basedsurvey in France

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    94. Wang, JX; Donnan, PT; Steinke, D; MacDonald, TM
      The multiple propensity score for analysis of dose-response relationships in drug safety studies

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    95. Langman, MJS
      Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    96. Cowles, RA; Mulholland, MW
      Surgical management of peptic ulcer disease in the helicobacter era-management of bleeding peptic ulcer

      SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES
    97. Rodriguez, LAG; Huerta-Alvarez, C
      Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

      EPIDEMIOLOGY
    98. Celotti, F; Laufer, S
      Anti-inflammatory drugs: New multitarget compounds to face an old problem.The dual inhibition concept

      PHARMACOLOGICAL RESEARCH
    99. Thurnher, D; Bakroeva, M; Formanek, M; Knerer, B; Kornfehl, J
      Non-steroidal anti-inflammatory drugs inhibit telomerase activity in head and neck squamous carcinoma cell lines

      HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    100. Park, BH; Breyer, B; He, TC
      Peroxisome proliferator-activated receptors: roles in tumorigenesis and chemoprevention in human cancer

      CURRENT OPINION IN ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 00:28:51